Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinsons Disease
NEJM 382:1926-1932, Schweitzer, J.S.,et al, 2020
Prevalence of Cerebral Amyloid Pathology in Persons without Dementia
JAMA 313-1924-1938,1913, Jansen, W.J.,et al, 2015
Prevalence of Amyloid PET Positivity in Dementia Syndromes
JAMA 313:1939-1949,1913, Ossenkoppele, R.,et al, 2015
PET Imaging for Alzheimer Disease: Are Its Benefits Worth the Cost?
JAMA 309:1099-1100, Mitka, M., 2013
�-Amyloid Burden in Healthy Aging
Neurol 78:387-395, Rodrigue,K.M.,et al, 2012
Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection
NEJM 367:885-887, Yang, L.,et al, 2012
Longitudinal Assessment of A-beta and Cognition in Aging and Alzheimer Disease
Ann Neurol 69:181-192, Villemagne,V.L.,et al, 2011
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Changing Concepts of Alzheimer Disease
JAMA 35:2458-2459, McKhann, G.M., 2011
Mild Cognitive Impairment
NEJM 362:2227-2234, Peterson, R.C., 2011
Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009
A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008
Brain Glucose Supply and The Syndrome of Infantile Neuroglycopenia
Arch Neurol 64:507-513, Pascual,J.M.,et al, 2007
Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006
PET of Brain Amyloid and Tau in Mild Cognitive Impairment
NEJM 355:2652-2663, Small,G.W.,et al, 2006
Whole-Body MRI and PET-CT in the Management of Cancer Patients
Eur Radiol 16:1216-1225, Schmidt,G.P.,et al, 2006
The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003
Functional Brain Mapping of Psychopathology
JNNP 72:432-439, Honey,G.D.,et al, 2002
Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001
Transplantation of Cultured Human Neuronal Cells for Patients With Stroke
Neurol 55:565-569, 467, Kondziolka,D. et al, 2000
Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998
Clinical, Neuroimaging, and Pathologic Features of Progressive Nonfluent Aphasia
Ann Neurol 39:166-173, Turner,R.S.,et al, 1996
Clinicopath Conf
Focal Cortical Dysplasia, Case 7-1996, NEJM 334:586-592996., , 1996
Neurological Sequelae of Cyanide Intoxication-The Patterns of Clinical MRI & Pet Findings
Ann Neurol 38:825-828, Rosenow,F.,et al, 1995
Funct'l Import of Ventric Enlarge & Cortical Atrophy in Healthy Subj & Alcoholics:PET, MR, & Neuropsych Testing
Radiology 186:59-65, Wang,G.,et al, 1993
New Anatomical and Functional Imaging Methods
Ann Neurol 32:395-400, Prichard,J.W.&Brass,L.M., 1992
Advances in Neurology
NEJM 326:1608-1616, 1671-16761992., Gilman,S., 1992
The Biology of Developmental Dyslexia
JAMA 268:912-915, Rumsey,J.M., 1992
HIV Encephalopathy and Dementia
Psychiatr Clin North Am 15:455-466, Pajeau,A.K.&Roman,G.C., 1992
Assessment:Positron Emission Tomography
Report of Therapeutics & Technology Assessment Subcommittee of the AAN, Neurol 41:163-16791., , 1991
PET:Its Clinical Role in Neurology
JNNP 54:1-5, Brooks,D.J., 1991
Posterior Cortical Dementia with Alexia:Neurobehavioural, MRI, and PET Findings
JNNP 54:443-448, Freedman,L.,et al, 1991
National Cancer Institute Workshop Statement
Advances in Clinical Imaging Using Positron Emission Tomography, Arch Int Med 150:735-739, 729990., , 1990
Cerebral Metabolic Asymmetries & Assoc Neuro-psych Patterns in Early Dementia of the Alzheimer Type
Arch Neurol 47:753-760, Haxby,J.V., 1990
Slowly Progressive Aphasia:Three Cases with Language, Memory, CT and PET Data
JNNP 53:987-993, Kempler,D.,et al, 1990
Clinical & PET Studies in the'Extrapyramidal Syndrome'of Dementia of the Alzheimer Type
Arch Neurol 47:1318-1323, Tyrrell,P.J.,et al, 1990
Plasticity in the Aging Brain
Arch Neurol 47:1336-1341, Kaye,J.A.,et al, 1990
The Marinesco-Sjogren Syndrome Examined by CT, MR, and 18F-2-Fluoro-2-Deoxy-D-Glucose & PET
Arch Neurol 47:1239-1242, Bromberg,M.B.,et al, 1990
Normal-Pressure Hydrocephalus and the Saga of the Treatable Dementias
JAMA 262:2577-2581, 2592-25931989., Friedland,R.P., 1989
Dementia in Down's Syndrome:Cerebral Glucose Utilization, Neuropsychological Assessment, and Neuropathology
Neurol 38:938-942, Schapiro,M.B.,et al, 1988
Brain Metabolism in Mitochondrial Encephalomyopathy:A PET Study
J Comput Assist Tomogr 12:854-857, DeVolder,A.,et al, 1988
Positron Emission Tomography-A New Approach to Brain Chemistry
JAMA 260:2704-2710, Jacobson,H.G., 1988
The Lennox-Gastaut Syndrome:Metabolic Subtypes Determined by FDG Positron Emission Tomography
Ann Neurol 21:4-13, Chugani,H.T.,et al, 1987
The Metabolic Pathology of the AIDS Dementia Complex
Ann Neurol 22:700-706, Rottenberg,D.A.,et al, 1987
Comparison of PET, MRI, & CT with Pathology in a Proven Case of Alzheimer's Disease
Neurol 36:1569-1574, McGeer,P.L.,et al, 1986
Alzheimer's Disease & Down's Syndrome:New Insights
Ann Int Med 103:566-578, Cutler,N.R.,et al, 1985